Total body potassium is profoundly depleted in DKA, even if the initial serum measurement appears normal or high (due to acidemia driving K⁺ out of cells). Initiating an IV insulin drip violently drives potassium back into the intracellular space. If serum K⁺ is < 3.3 mEq/L, starting insulin will trigger catastrophic, fatal hypokalaemia (respiratory paralysis, cardiac arrest). You MUST hold insulin and aggressively replace potassium first.
Hyperglycaemia raises serum osmolality, pulling intracellular water into the extracellular space and artificially diluting the serum sodium concentration.
Formula: Corrected Na⁺ = Measured Na⁺ + 1.6 × [(Glucose - 100) / 100]
Always use the corrected sodium to guide your fluid choice. Using uncorrected sodium will cause you to erroneously administer 0.9% NaCl, leading to hyperchloraemic metabolic acidosis, which artificially masks the resolution of the anion gap.
A classic error is stopping the insulin drip the moment blood glucose drops below 200 mg/dL. This instantly halts the suppression of ketogenesis, plunging the patient back into DKA. When glucose hits 200 mg/dL, you must add 5% Dextrose (D5W) to the IV fluids and halve the insulin drip rate. You are now “clamping” the glucose while keeping the insulin running to chemically clear the ketones.
- DKA Resolution: Blood glucose < 200 mg/dL AND two of the following: Serum bicarbonate ≥ 15 mEq/L, venous pH > 7.30, calculated anion gap ≤ 12 mEq/L.
- HHS Resolution: Normal osmolality and recovery of normal mental status.
- Transition Protocol: You MUST administer the first dose of subcutaneous basal insulin 1 to 2 hours BEFORE stopping the IV insulin infusion to prevent rebound ketoacidosis.
Algorithm References & Evidence Base
- American Diabetes Association. Standards of Medical Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1).
- Kitabchi AE, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335-1343.
- Fayfman M, et al. Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State. Med Clin North Am. 2017;101(3):587-606.
Access all evidence-based algorithms, prognostic matrices, and pharmacotherapeutic pathways.
← View All Clinical Modules
